This region is also expected to experience the highest growth rate during the forecast period 2015 to 2023.

1. Antibacterial Drugs Market Detailed Analysis and Forecast by
2023
Report Description
An antibacterial drug is referred to as an antimicrobial agent
interfering with the growth and reproduction of bacteria that
cause numerous mild to severe infections in humans and

2. animals. Antibacterial drugs either kill or inhibit their
growth. These agents possess bactericidal activity which
target various parts of bacterial physiology such as protein
synthesis, cell wall synthesis, nucleic acid synthesis and
permeability of cell membrane, and therefore help in treating
infections. Antibacterial drugs are being in use since the
discovery of the first antibacterial in the form of penicillin in
1928, and presently a wide range of antibacterials in several
formulations are commercially available and used for the
treatment of various indications like pneumonia, tuberculosis,
tetanus, diphtheria, diarrhea, legionellosis and other
diseases.

3. Request a Sample Copy of the Report @
http://www.mrrse.com/sample/1040
The global antibacterial drugs market has been categorized
into eight segments based on their class which include:
aminoglycosides, -lactams, tetracyclines, sulfonamides,β
quinolones/ fluoroquinolones, macrolides, phenicols, and
miscellaneous antibacterials. In 2014, -lactams occupied theβ
leading position with a share of 57.7% of the global
antibacterial drugs market followed by the quinolones.
However, these drug classes are expected to witness a decline
in their market share during the forecast period due to
scheduled patent expiry of key branded formulations, coupled
with growing number of drug resistant bacterial strains and

4. increasing influx of generic drugs. Hence, on account of the
factors mentioned above, the global antibacterial drugs
market is expected to witness slow growth during the forecast
period 2015 to 2023. However, the miscellaneous
antibacterials segment is expected to grow with the highest
CAGR accompanied with growing demand for therapies
against bacterial infections and rising geriatric populations
are some of the factors that are anticipated to maintain the
growth of the antibacterial drugs market. Additionally,
expected commercialization of various antibacterial agents
that are currently in developmental stages, such as
solithromycin (Cempra, Inc.), VivaGel (SPL7013) (Starpharma
Holdings Limited), surotomycin (Merck & Co.) MK-3415A

5. (Merck & Co.) during the forecast period is also expected to
profound impact on growth of this market.
Inquiry on this report @ http://www.mrrse.com/enquiry/1040
Asia-Pacific held the largest share of the revenue generated
by the global antibacterial drugs market in 2014. This region
is also expected to experience the highest growth rate during
the forecast period 2015 to 2023. The major factors
responsible for this region to hold leadership in this market
in 2014 include presence of large number of generic
manufacturers and active pharmaceutical ingredient (API)
manufacturers in Asian countries, growing incidences of

6. bacterial infections such as MRSA (methicillin resistant
Staphylococcus aureus) and tuberculosis and increasing
purchasing power of the domestic population. Moreover,
developing health care infrastructure, presence of a large
population base and growing geriatric population which is
more prone to diseases would consequently increase the
uptake of antibacterial drugs in Asia. North America held the
second largest revenue share followed by Europe in the
antibacterial drugs market in 2014. Market maturity,
shortened product lifecycle, stringent regulatory requirements
and generic infiltration are some of the factors that
accounted for slow growth of this market.

7. Read Complete Report @ http://www.mrrse.com/antibacterial-
drugs-market
AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company,
Eli Lilly and Company, Allergen plc, GlaxoSmithKline plc,
Johnson & Johnson Services, Inc., Merck & Co., Inc.,
Novartis AG, Pfizer, Inc., and Sanofi are the major players
engaged in the development, production and marketing of
various antibacterial drugs. These players have worldwide
presence in the pharmaceutical industry and are involved in
constant competition with each other. Pfizer, Inc. was
observed to be the most promising and leading player in the
Antibacterial drugs market. Major customers for their

8. antibacterial drugs include hospitals, private clinics,
physicians and patients.
About MRRSE
MRRSE stands for Market Research Reports Search Engine,
the largest online catalog of latest market research reports
based on industries, companies, and countries. MRRSE
sources thousands of industry reports, market statistics, and
company profiles from trusted entities and makes them
available at a click. Besides well-known private publishers,
the reports featured on MRRSE typically come from national
statistics agencies, investment agencies, leading media houses,
trade unions, governments, and embassies.

9. Contact US:
Corporate Office
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-730-0559
Email: sales@mrrse.com